Patents Assigned to PHAROSGEN CO., LTD.
  • Prodrugs activated by caspase
    Patent number: 10357572
    Abstract: Described are prodrug conjugates that release a chemotherapeutic agent upon activation by caspase, and methods using such prodrug conjugates to induce apoptosis, amplify apoptosis, and treat cancer.
    Type: Grant
    Filed: August 29, 2017
    Date of Patent: July 23, 2019
    Assignee: PHAROSGEN CO., LTD.
    Inventors: Sang-Yoon Kim, Youngro Byun, Seung Woo Chung
  • PRODRUGS ACTIVATED BY CASPASE
    Publication number: 20180185498
    Abstract: Described are prodrug conjugates that release a chemotherapeutic agent upon activation by caspase, and methods using such prodrug conjugates to induce apoptosis, amplify apoptosis, and treat cancer.
    Type: Application
    Filed: August 29, 2017
    Publication date: July 5, 2018
    Applicant: Pharosgen Co., Ltd.
    Inventors: Sang-Yoon KIM, Youngro Byun, Seung Woo Chung
  • Prodrugs activated by caspase
    Patent number: 9775914
    Abstract: Described are prodrug conjugates that release a chemotherapeutic agent upon activation by caspase, and methods using such prodrug conjugates to induce apoptosis, amplify apoptosis, and treat cancer.
    Type: Grant
    Filed: July 10, 2015
    Date of Patent: October 3, 2017
    Assignee: PHAROSGEN CO., LTD.
    Inventors: Sang-Yoon Kim, Youngro Byun, Seung Woo Chung